488 related articles for article (PubMed ID: 17595539)
1. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
Airley RE; Mobasheri A
Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
[TBL] [Abstract][Full Text] [Related]
2. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.
Barron CC; Bilan PJ; Tsakiridis T; Tsiani E
Metabolism; 2016 Feb; 65(2):124-39. PubMed ID: 26773935
[TBL] [Abstract][Full Text] [Related]
3. [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].
Jóźwiak P; Lipińska A
Postepy Hig Med Dosw (Online); 2012 Jan; 66():165-74. PubMed ID: 22470192
[TBL] [Abstract][Full Text] [Related]
4. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Evans A; Bates V; Troy H; Hewitt S; Holbeck S; Chung YL; Phillips R; Stubbs M; Griffiths J; Airley R
Cancer Chemother Pharmacol; 2008 Mar; 61(3):377-93. PubMed ID: 17520257
[TBL] [Abstract][Full Text] [Related]
5. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro.
Pedersen MW; Holm S; Lund EL; Højgaard L; Kristjansen PE
Neoplasia; 2001; 3(1):80-7. PubMed ID: 11326319
[TBL] [Abstract][Full Text] [Related]
6. Expression of glucose transporters in cancers.
Szablewski L
Biochim Biophys Acta; 2013 Apr; 1835(2):164-9. PubMed ID: 23266512
[TBL] [Abstract][Full Text] [Related]
7. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes.
Mobasheri A; Richardson S; Mobasheri R; Shakibaei M; Hoyland JA
Histol Histopathol; 2005 Oct; 20(4):1327-38. PubMed ID: 16136514
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia preconditioning protects neuronal cells against traumatic brain injury through stimulation of glucose transport mediated by HIF-1α/GLUTs signaling pathway in rat.
Wu X; Wang C; Wang J; Zhu M; Yao Y; Liu J
Neurosurg Rev; 2021 Feb; 44(1):411-422. PubMed ID: 31897883
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
Macheda ML; Rogers S; Best JD
J Cell Physiol; 2005 Mar; 202(3):654-62. PubMed ID: 15389572
[TBL] [Abstract][Full Text] [Related]
11. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporters in cancer - from tumor cells to the tumor microenvironment.
Ancey PB; Contat C; Meylan E
FEBS J; 2018 Aug; 285(16):2926-2943. PubMed ID: 29893496
[TBL] [Abstract][Full Text] [Related]
13. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
14. Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.
Busk M; Horsman MR; Kristjansen PE; van der Kogel AJ; Bussink J; Overgaard J
Int J Cancer; 2008 Jun; 122(12):2726-34. PubMed ID: 18351643
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1.
Baumann MU; Zamudio S; Illsley NP
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C477-85. PubMed ID: 17442736
[TBL] [Abstract][Full Text] [Related]
16. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Cao X; Fang L; Gibbs S; Huang Y; Dai Z; Wen P; Zheng X; Sadee W; Sun D
Cancer Chemother Pharmacol; 2007 Mar; 59(4):495-505. PubMed ID: 16906425
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucose transport by hypoxia.
Zhang JZ; Behrooz A; Ismail-Beigi F
Am J Kidney Dis; 1999 Jul; 34(1):189-202. PubMed ID: 10401038
[TBL] [Abstract][Full Text] [Related]
18. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Airley R; Loncaster J; Davidson S; Bromley M; Roberts S; Patterson A; Hunter R; Stratford I; West C
Clin Cancer Res; 2001 Apr; 7(4):928-34. PubMed ID: 11309343
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.
Chen JQ; Russo J
Biochim Biophys Acta; 2012 Dec; 1826(2):370-84. PubMed ID: 22750268
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
